Form EFFECT ENANTA PHARMACEUTICALS
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 20, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lianlian DigiTech at Money20-20 Europe Exploring the AI-Driven Global Payments Ecosystem
- RAIN Highlights $200M Ecosystem Commitment, $100M Liquidity Expansion, and Growth Strategy Ahead of Version 2 Launch
- Best Crypto Coins: Crypto Tax Reform Gains Momentum As APEMARS Leads The Next 100x Coin Narrative Beside Pepe And Fartcoin
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share